P R O T O C O L B O O K L E T B I A N C A M A R I A S T I V A L A
|
|
- Shauna Stanley
- 5 years ago
- Views:
Transcription
1 P R O T O C O L S I N E YE C O N D I T I O N S P R O T O C O L B O O K L E T B I A N C A M A R I A S T I V A L A
2 This booklet was compiled by Bianca Maria Stivala as part of an undergraduate project entitled Protocols in Eye Conditions carried out for the partial fulfilment of the requirements of the course leading to the Degree of Bachelor of Pharmacy (Honours). The study was carried out under the supervision of Professor Lilian M. Azzopardi, Head of Department, Department of Pharmacy, University of Malta. The validation panel: Dr Joseph Farrugia MD Demis Fsadni B.Pharm. (Hons.) Dr Marco Grech MD, Cert. Diab. (ICGP), MMCFD Dr Jan Janula MD, PhD, SDSOph (Prague) Mr Franco Mercieca MD, FRCOphth (UK) Mark Mercieca B. Pharm. (Hons.) Sponsored by: Actavis Malta Ltd. Printed by: FiveStar Printing Ltd. The author makes no representation, expressed or implied, with regards to the accuracy of the information contained in this booklet and cannot accept any legal responsibility or liability for any errors or omissions that may be made. Bianca Maria Stivala Department of Pharmacy Faculty of Medicine and Surgery University of Malta Msida, Malta Published in August 2011
3 P R O T O C O L S I N E YE C O N D I T I O N S B I A N C A M A R I A S T I V A L A
4 P R E F A C E Pharmacists are commonly consulted about the management of signs and symptoms of common eye conditions. Pharmacists are in a position to identify signs and symptoms that require immediate referral. They are in a position to support patients in selfmanagement of dryness, conjunctivitis and external segment and eyelid conditions. In the management of eye conditions patients need to be educated about the proper use of ophthalmic medications. The protocols presented in this handbook have been developed by Bianca Maria Stivala, a pharmacy student as part of her project. This project is part of a research study being undertaken at the Department of Pharmacy with the aim of developing and disseminating protocols for the local scenario that are evidencebased. Professor Lilian M.Azzopardi Head, Department of Pharmacy
5 C O N T E N T S How to use this booklet 2 Interpretation of shapes 3 Protocol for External Segment & Eyelid Conditions 4 Protocol for Conjunctivitis 10 Protocol for Dry Eye Disease 15 References 21
6 H OW TO U S E T H I S B O O K L E T This booklet contains three flow chart protocols whose aim is to guide pharmacists in diagnosing and managing ocular conditions and recognising conditions which warrant referral. The protocols are guidelines compiled using evidence-based medicine, which when coupled with the pharmacist s experience provide the best pharmaceutical care to the patient. This booklet is to be used with a companion explanatory text handbook which contains explanations and references for each protocol step. The text which corresponds with treatment and management steps provides more detail about pharmacological and non-pharmacological patient advice, which is of practical significance. The handbook is available online as a downloadable and printable A4 size document entitled Protocols in Eye Conditions Handbook at URL 2
7 I N T E R P R E T A T I O N OF S H A P E S Data box Known information about the patient Action box Pharmacist is required to perform an action Decision box Pharmacist is required to make a decision which leads to different paths Connector box Directs pharmacist to another step on another page Terminator box Pharmacist is required to perform an action and exit the protocol 3 Step number label 3
8 E X T E R N A L S E G M E N T & E Y E L I D C O N D I T I O N S Patient presents with inflammation of the eyelid and/or eyelid margin 1 2 Pharmacist greets patient 4 3 Is pharmacist familiar with patient? Pharmacist asks questions to know identity of patient. Go to box Does patient wear contact Refer lenses? 7 Is there any lump or localised swelling present? Go to box 8 Go to box 25 4
9 From box 7 8 Is there any redness on the lump? There is no redness on the lump 9 10 Patient reports tenderness to touch Go to box Is the lump painful? Swelling is tender but not painful Check if swelling points towards lid margin or towards conjunctiva Go to box 15 Go to box 14 5
10 E X T E R N A L S E G M E N T & E Y E L I D C O N D I T I O N S From box Does swelling point towards lid margin? 15 Chalazion (meibomian cyst) 19 Does the redness have a white/ yellowish core? Evert patient s eyelid after cl hands with an appropriate c agent 20 External hordeolum (stye) Is there any pus on the inside of the eyelid? Treatment 21 Warm compresses applied 3-4 times daily for minutes. Internal hordeolum Refer to general practitioner as antibiotic therapy is required. 6
11 16 Did patient ever manifest these symptoms before? Refer 17 eaning leaning 22 Treatment Warm compresses applied twice daily for 3-5 minutes. The lesion should be massaged in the direction of the eyelashes with clean fingers or cotton tips. 18 Refer to general practitioner if swelling does not subside or becomes red
12 E X T E R N A L S E G M E N T & E Y E L I D C O N D I T I O N S From box Does patient have seborrhoeic dermatitis of scalp and/or eyebrows? Are there gr scales presen the eyelid 30 Are there dry scales present on the eyelid margin? Go to box 26 Seborrhoeic ble 31 Are there greasy scales also present? Staphylococcal bleph 33 Mixed infection blepharitis Treatment Warm compresses applied for seve Eyelid hygiene once daily or as oft effective may be required on a long Refer to general practitioner for appro 8
13 easy t on? Meibomian gland dysfunction (posterior blepharitis) 28 pharitis 27 Treatment Warm compresses applied for several minutes. Eyelid hygiene once daily or as often as required. If effective may be required on a long-term basis. Keep scalp, eyebrows, and other areas affected by seborrhoeic dermatitis clean by means of soap and water shampoo. Refer to general practitioner for appropriate antibiotic therapy. 29 aritis ral minutes. en as required. If -term basis. priate antibiotic therapy. 9
14 C O N J U N C T I V I T I S Patient presents with a red eye 1 2 Pharmacist greets patient 4 3 Is pharmacist familiar with the patient? Pharmacist asks questions to know identity of patient. Go to box 5. 5 Are the eyes painful? Refer 6 7 Does the patient wear contact lenses? Refer 8 Go to box 9 10
15 From box 7 9 Does the patient have physical injury? Refer Check if redness is unilateral or bilateral. 11 Refer 12 Are symptoms unilateral? 13 Have symptoms been unilateral for more than 2 days? 15 Were symptoms initially unilateral? 16 Infectious conjunctivitis Go to box 22 Go to box 17 11
16 C O N J U N C T I V I T I S From box Symptoms were always bilateral 18 Are the eyes itchy? Refer Allergic conjunctivitis Treatment 21 n-pharmacological advice: Minimise exposure to allergens as much as possible Wash clothes and fabric frequently Shower/bathe before bedtime Cool compresses to alleviate itching and remove any dry crusts Pharmacological treatment: Topical antihistamine/vasoconstrictor agent Topical histamine H1-receptor antagonist (levocabastine, emedastine) Artificial tears to dilute allergens (carboxymethyl cellulose, hydroxypropyl methylcellulose) For recurrent or persistent cases: mast cell stabilisers (sodium cromoglicate) 12
17 From box Is there any discharge present? Refer 24 Is the discharge 25 purulent/ mucopurulent? Is the discharge serous (watery)? Bacterial conjunctivitis Adenoviral conjunctivitis Go to box 29 Treatment Supportive treatment with cool compresses, artificial tears and/or topical antihistamines. Give advice on good hygiene to prevent spread of infection (frequent hand washing, avoid sharing of towels and facecloths with other people) to other people and/or the other eye in cases where infection is still unilateral. Advise patient that infection remains contagious for up to 2 weeks after the second eye becomes infected. 27 Refer to specialist if symptoms do not resolve within 2 weeks. 13
18 C O N J U N C T I V I T I S From box Is there a palpable preauricular node? Chlamydial inclusion conjunctivitis Is there associated blepharitis? Acute bacterial conjunctivitis Refer Chronic bacterial conjunctivitis Treatment Warm compresses and eyelid hygiene to remove blepharitis crusts. Refer to specialist for antibiotic treatment
19 D RY E YE D I S E A S E 1 Patient presents with complaint of foreign body sensation 2 Pharmacist greets patient 3 Is pharmacist familiar with patient? Pharmacist asks questions to know identity of patient. Go to box Does patient wear contact Refer lenses? 7 Does the eye appear red? See conjunctivitis protocol 8 Go to box 9 15
20 D RY E YE D I S E A S E From box 7 Management 9 Does patient manifest symptoms of posterior blepharitis? Eyelid hygiene and Artificial tears app Increase intake of f reduce alcohol inge Refer to ophthalmolog 11 Is the patient exposed to cigarette smoke? 12 Dry eye due to expo to cigarette smok 14 Is the patient using any topical products? 15 Dry eye due to use o topical products Go to box 17 16
21 10 warm compresses applied at least once daily. lied 3-4 times daily or as required. oods containing omega-3 fatty acids and vitamin A; stion. ist is symptoms to not improve after one week. Management 13 sure e Reduce exposure to cigarette smoke. Increase intake of foods containing omega-3 fatty acids and vitamin A; reduce alcohol ingestion. Artificial tears applied 3-4 times daily or as required. Management 16 f If patient is taking non-prescription medications: Advise patient to stop taking medication or suggest alternatives without preservatives. Dispense artificial tears to be applied 3-4 times daily or as required. Advise patient to wait 15 minutes before applying second product. If patient is taking prescription medications, refer to ophthalmologist for re-evaluation of treatment. 17
22 D RY E YE D I S E A S E From box Is the patient female? 18 Is the patient taking oestrogen only HRT? 20 Is patient taking any systemic medications? Go to box Does the patient have symptoms of dry mouth? Sjögren s syndrome Refer to rheumatologist 22 18
23 Refer 19 Dry eye as a side-effect of systemic medication 23 Management 24 If patient is taking non-prescription medications: Advise patient to stop taking medications. Dispense artificial tears to be applied 3-4 times daily or as required. If symptoms do not improve refer to ophthalmologist. If patient is taking medications with specialist prescription, refer patient to specialist for re-evaluation of treatment. 19
24 D RY E YE D I S E A S E From box Does the patient spend a long time in front of a screen or reading? Refer Episodic dry eye due to extended visual tasking Management 27 Environmental modifications: control humidity, take frequent breaks when using computer, blink frequently. Dietary modifications: increase intake of foods containing omega-3 fatty acids and vitamin A; reduce alcohol ingestion. Pharmacotherapy: artificial tears 3-4 times daily or as required. Refer to ophthalmologist if symptoms do not improve or if patient reports frequent use of artificial tears. 20
25 R E F E R E N C E S American Academy of Ophthalmology Cornea/External Disease Panel. Preferred Practice Pattern Guidelines. Blepharitis. San Francisco, CA: American Academy of Ophthalmology; American Academy of Ophthalmology Cornea/External Disease Panel. Preferred Practice Pattern Guidelines. Conjunctivitis. San Francisco, CA: American Academy of Ophthalmology; American Academy of Ophthalmology Cornea/External Disease Panel. Preferred Practice Pattern Guidelines. Dry Eye Syndrome. San Francisco, CA: American Academy of Ophthalmology; Bertino JS. Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics. Clinical Ophthalmology 2009; 3: Blenkinsopp A, Paxton P, Blenkinsopp J. Symptoms in the Pharmacy: A guide to the management of common illness. 5 th ed. Oxford (UK): Blackwell Publishing Ltd.; Gaby AR. Nutritional Therapies for Ocular Disorders: Part Three. Altern Med Rev 2008; 13(3): Galor A, Jeng BH. Red eye for the internist: When to treat, when to refer. Cleve Clin J Med 2008; 75(2): Gayton J. Etiology, prevalence, and treatment of dry eye disease. Clinical Ophthalmology 2009; 3: Gilchrist H, Lee G. Management of chalazia in general practice. Aust Fam Physician 2009; 38(5): Granet D. Allergic rhinoconjunctivitis and differential diagnosis of the red eye. Allergy Asthma Proc 2008; 29: Høvding G. Acute bacterial conjunctivitis. Acta Ophthalmol 2008; 86: Khurana AK. Comprehensive Ophthalmology. 4 th ed. New Delhi (India): New Age International (P) Ltd.;
26 R E F E R E N C E S Manaviat MR, Rashidi M, Afkhami-Ardekani M, Shoja MR. Prevalence of dry eye syndrome and diabetic retinopathy in type 2 diabetic patients. BMC Ophthalmol 2008; 8:10. Martin EA, editor; Oxford Concise Colour Medical Dictionary. 4th ed. Oxford (UK): Oxford University Press; Morrow GL, Abbott RL. Conjunctivitis. American Family Physician. February 15, Available at: Riordan-Eva P, Whitcher JP, editors; Vaughan & Asbury s General Ophthalmology. 17 th ed. USA: McGraw-Hill Lange; Schlote T, Rohrbach J, Grueb M, Mielke J. Pocket Atlas of Ophthalmology. Stuttgart (Germany): Thieme; Sharma NS, Ooi JL, Li MZ. A painful red eye. Aust Fam Physician 2009; 38(10): Tarabishy AB, Jeng BH. Bacterial conjunctivitis: A review for internists. Cleve Clin J Med 2008; 75(7):
27
28
Blepharitis. Information for patients Ophthalmology (Emergency Eye Centre) Large Print
Blepharitis Information for patients Ophthalmology (Emergency Eye Centre) Large Print page 2 of 12 Blepharitis is a condition where the rims of the eyelids become inflamed (red and swollen), which can
More informationLecture No. :3 صيدلة سريرية م.د : ضياء جبار
College of Pharmacy Fourth Year. Clinical Pharmacy 2016-2017 Minor Eye Disorders 1-Conjunctivitis Redness of the eye is one of the common ophthalmic problems seen in the community pharmacy and conjunctivitis
More informationPRESCRIBING INFORMATION
PRESCRIBING INFORMATION OPTIMYXIN Gramicidin and Polymyxin B Sulfate Oto-Ophthalmic Solution sterile Eye/Ear Drops Antibiotic Sandoz Canada Inc. Date of Revision: November 25, 2015 145 Jules-Léger Boucherville,
More informationNasolacrimal Duct Blockage
The eyelids play a key role in protecting the eyes. They help spread moisture (tears) over the surface of the eyes when they close (for example, while blinking); thus, they help prevent the eyes from becoming
More informationChalazia can recur, and those that do should be evaluated for malignancy.
DEFINITION Chalazia (plural of chalazion) are the most common inflammatory lesions of the eye lid. These are slowly enlarging eyelid nodules, formed by inflammation and obstruction of sebaceous glands.
More informationSepideh Tara Rousta, MD FAAO Robert Wood Johnson University Hospital Saint Peter s University Hospital Wills Eye Hospital
Sepideh Tara Rousta, MD FAAO Robert Wood Johnson University Hospital Saint Peter s University Hospital Wills Eye Hospital 14 mo old w R eye cross (parents) 9 mo old R eye crossing getting worse for past
More informationTENTATIVE DIAGNOSES Based on the information provided so far, what are the potential diagnoses?
Kallendorf-Case Study #4 PEDIATRIC CASE STUDY SCENARIO Mary Jennings has brought her son Joe to your office. Joe is a 6-year old Jordanian male. He presents with the complaint of an itchy red eye. Mary
More informationNORTHEAST OHIO NEIGHBORHOOD HEALTH SERVICES, INC. OPTOMETRIC MEDICINE CLINICAL GUIDELINES: TABLE OF CONTENTS
NORTHEAST OHIO NEIGHBORHOOD HEALTH SERVICES, INC. OPTOMETRIC MEDICINE CLINICAL GUIDELINES: 2012-2013 TABLE OF CONTENTS CONDITION PAGE(S) Complete Eye and Vision Examination 2 Vision Screening Procedure
More informationExamining Children s Eyes
Paediatric Ophthalmology What to refer & when? Aims Tips for assessing a child s eyes in general practice Common paediatric ophthalmology symptoms and signs What needs to be referred and when? MISS FARIHA
More informationDry Eye Syndrome (DES)
Dry Eye Syndrome (DES) (1) What is Dry eye syndrome (DES)? (2) What causes dry eye syndrome? (3) What are the features of dry eye syndrome? (ii) Irritation and dry eyes This occurs because without adequate
More informationTENTATIVE DIAGNOSES Based on the information provided so far, what are the potential diagnoses?
Case Study #4 PEDIATRIC CASE STUDY SCENARIO Mary Jennings has brought her son Joe to your office. Joe is a 6-year old Jordanian male. He presents with the complaint of an itchy red eye. Mary states that
More informationDRY EYE INFORMATION AND TREATMENTS
DRY EYE INFORMATION AND TREATMENTS If you cannot come to your appointment, please call us at least 24 hours before at 450.419.6345. Failure to notify us will result in a $50 fee being charged. Institut
More informationOphthalmic Antihistamine Step Therapy Program Summary
Ophthalmic Antihistamine Step Therapy Program Summary FDA APPROVED INDICATIONS AND DOSAGE 1-8 Drug FDA Indication(s) Administration and Dosing Bepreve Treatment of itching associated Instill one drop into
More informationLUMIGAN EYE DROPS (bimatoprost 0.3 mg per ml)
LUMIGAN EYE DROPS (bimatoprost 0.3 mg per ml) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about LUMIGAN eye drops. It does not contain all the available
More informationDry Eye. A Closer Look
Dry Eye. A Closer Look What is dry eye? Normally, the eye constantly bathes itself in tears. By producing tears at a slow and steady rate, the eye stays moist and comfortable. Sometimes people do not produce
More informationOOGZIEKTEN VOOR DE HUISARTS F. GOES, JR.
OOGZIEKTEN VOOR DE HUISARTS F. GOES, JR. HET RODE OOG F. GOES, JR. Condition Signs Symptoms Causes Conjunctivitis Viral Normal vision, normal pupil size Mild to no pain, diffuse Adenovirus (most common),
More informationPATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM RELESTAT, epinastine hydrochloride 0,5 mg/ml, eye drops
Page 1 of 5 SCHEDULING STATUS Schedule 2 PATIENT INFORMATION LEAFLET PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM RELESTAT, epinastine hydrochloride 0,5 mg/ml, eye drops Read all of this leaflet
More informationPeople with eye allergies typically have symptoms that include: Eye Anatomy: What Do Eye Allergies Actually Effect?
Eye Allergies Eye Allergies People with eye allergies typically have symptoms that include: Itchy watery eyes Eyelid problems Dark circles around eyes Dry eyes Reactions to Contacts Let us help allow you
More informationOCULAR ALLERGY IN CHILDREN. Presenter: Dr C.L.A Ogundo Consultant Ophthalmologist KPA conference April 2017
OCULAR ALLERGY IN CHILDREN Presenter: Dr C.L.A Ogundo Consultant Ophthalmologist KPA conference April 2017 Introduction Hypersensitivity disorder Conjunctival surface is accessible to allergens and is
More informationACULAR EYE DROPS 5 mg/ml Eye Drops
ACULAR EYE DROPS 5 mg/ml Eye Drops (ketorolac trometamol) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about ACULAR eye drops, including how to use the
More informationVision Health: Conditions, Disorders & Treatments EYELID DISORDERS
Vision Health: Conditions, Disorders & Treatments EYELID DISORDERS There are a number of disorders that can affect the eyelid. Entropion Entropion is an inward turning of the eyelid and lashes toward the
More informationa.superficial (adenoid layer).contain lymphoid tissue.
Conjunctiva Dr. saifalshamarti Anatomy Microscopic: 1.Epithelium (non keratinized,includes goblet cell). 2.Epithelial basement membrane. 3.Stroma : a.superficial (adenoid layer).contain lymphoid tissue.
More informationRED EYE, RED EYE What do YOU See???
RED EYE, RED EYE What do YOU See??? The role of the front office and optometric assistant in the detection and treatment of RED EYES Front office staff and assistants are THE first ones to begin the RED
More informationTHE RED EYE Cynthia McNamara, MD Week 25
THE RED EYE Cynthia McNamara, MD Week 25 Educational Objectives: 1. Know the differential diagnosis and presentation of specific etiologies of the red eye 2. Be able to evaluate patients presenting with
More informationAPO-Olopatadine Eye Drops Contains the active ingredient olopatadine (as olopatadine hydrochloride)
APO-Olopatadine Eye Drops Contains the active ingredient olopatadine (as olopatadine hydrochloride) Consumer Medicine Information For a copy of a large print leaflet, Ph: 1800 195 055 What is in this leaflet
More information9/23/2014. Emily Thomas, O.D. MOA Paraoptometric Education October 5, 2014
Emily Thomas, O.D. MOA Paraoptometric Education October 5, 2014 Anterior toward the front of the body Posterior toward the rear of the body Unilateral only one eye involved Bilateral both eyes involved
More informationBruce H. Koffler, M.D. Lindsay Koffler Cassidy, COT, OSC
Bruce H. Koffler, M.D. Lindsay Koffler Cassidy, COT, OSC Ocular surface disease patients can be very time consuming. You must have a streamlined system and work as a team in order to effectively run a
More informationDry Eye Prescribing Guidelines
Dry Eye Prescribing Guidelines Amendment History VERSION DATE AMENDMENT HISTORY V1.0 2011 Comments V1.1 2013 Updated V1.1 2017 Draft Updated Thealoz Duo replaces carmellose Optive in severe dry eye on
More informationZADITEN Eye Drops 1.0%
ZADITEN Eye Drops 1.0% Ketotifen Consumer Medicine Information What is in this leaflet Please read this leaflet carefully before you use Zaditen Eye Drops. This leaflet answers some common questions about
More informationMeibomian Gland Dysfunction: What Does It Mean James P. McCulley, MD, FACS, FRCOph(UK)
Meibomian Gland Dysfunction: What Does It Mean James P. McCulley, MD, FACS, FRCOph(UK) David Bruton, Jr. Professor of Ophthalmology Chairman, Department of Ophthalmology The University of Texas Southwestern
More informationDry eye syndrome. Lacrimal gland. Tear duct into nose. 1 of 6
Dry eye syndrome The aim of this information sheet is to answer any questions you may have about dry eye syndrome. If you have any further questions or concerns, please ask a doctor or nurse caring for
More informationPilocarpine 2% w/v Eye Drops, solution. Pilocarpine 4% w/v Eye Drops, solution. Pilocarpine Hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER Pilocarpine 2% w/v Eye Drops, solution Pilocarpine 4% w/v Eye Drops, solution Pilocarpine Hydrochloride (Referred to as Pilocarpine Eye Drops in this leaflet)
More informationDiagnosing a red eye: an allergy or an infection?
Diagnosing a red eye: an allergy or an infection? L Lambert Correspondence to: Lynn Lambert, e-mail: lynn@amayeza-info.co.za Keywords: red eye, allergy, infection, inflammation,, viral, bacterial Abstract
More informationA case of recalcitrant bacterial conjunctivitis
A case of recalcitrant bacterial conjunctivitis Aboshiha J. A case of recalcitrant bacterial conjunctivitis. Practitioner 2013; 257 (1766):25-28 Mr Jonathan Aboshiha MA(Cantab) MRCS(Ed) FRCOphth Clinical
More informationDoxycycline for stye on eye
Doxycycline for stye on eye The Borg System is 100 % Doxycycline for stye on eye Sep 3, 2015. Several different types of red, swollen and tender bumps can arise on the edge or inside portions of an eyelid,
More informationBrinzoQuin Eye Drops 1.0%
BrinzoQuin Eye Drops 1.0% Brinzolamide Consumer Medicine Information What Is In This Leaflet Read this leaflet carefully before you start to use BrinzoQuin Eye Drops. This leaflet has been written to answer
More informationNEVANAC TM 0.1% Eye Drops
NEVANAC TM 0.1% Eye Drops Nepafenac CONSUMER MEDICINE INFORMATION What is in this leaflet Please read this leaflet carefully before you use Nevanac Eye This leaflet answers some common questions about
More informationAndrew J. Hendershot, MD Havener Eye Institute The Ohio State University s Wexner Medical Center
Ocular Trauma for the Primary Care Physician Andrew J. Hendershot, MD Havener Eye Institute The Ohio State University s Wexner Medical Center Relevance Often those with minor eye injuries will first seek
More informationPackage leaflet: Information for the user. NEVANAC 1 mg/ml eye drops, suspension Nepafenac
Package leaflet: Information for the user NEVANAC 1 mg/ml eye drops, suspension Nepafenac Read all of this leaflet carefully before you start using this medicine because it contains important information
More informationSUBMISSION FOR RECLASSIFICATION OF MEDICINE. ZADITEN (KETOTIFEN 0.025% for Ophthalmic Use) TT , TT /1
SUBMISSION FOR RECLASSIFICATION OF MEDICINE ZADITEN (KETOTIFEN 0.025% for Ophthalmic Use) TT50-7009, TT50-7009/1 June 2008 PART A 1. International non-proprietary name Ketotifen 2. Proprietary name Zaditen
More informationDr Rachael Neiderer. Ophthalmologist Auckland. 8:35-8:50 Managing Allergic Conjunctivitis & Why Sodium Chromoglycate is Out
Dr Rachael Neiderer Ophthalmologist Auckland 8:35-8:50 Managing Allergic Conjunctivitis & Why Sodium Chromoglycate is Out Allergic conjunctivitis Rachael Niederer Greenlane Clinical Centre, Auckland Case
More informationDiagnosing a red eye: an allergy or an infection?
South African Family Practice 2015; 57(1):29-33 Open Access article distributed under the terms of the Creative Commons License [CC BY-NC-ND 4.0] http://creativecommons.org/licenses/by-nc-nd/4.0 S Afr
More informationPATIENT GUIDE TO LUMIGAN 0.01%
Treatment Tracker enclosed PATIENT GUIDE TO LUMIGAN 0.01% LUMIGAN (bimatoprost ophthalmic solution) 0.01% is used for the treatment of high eye pressure, also called intraocular pressure (IOP), in people
More informationPAINFUL PAINLESS Contact lens user BOV
Common Causes Allergies Infections Ocular Cornea, uveitis, endophthalmitis Orbital Orbital cellulitis Inflammation Uveitis Scleritis / episcleritis Glaucomas Trauma Foreign bodies Chemical injuries History
More informationAcute Eyes for ED. Enis Kocak. The Alfred Ophthalmology
Acute Eyes for ED Enis Kocak The Alfred Ophthalmology The problem with eyes Things to cover Ocular anatomy Basic assessment Common presentations Eye first aid and procedures Ophthalmic emergencies What
More informationPackage leaflet: Information for the user. Relestat, 0.5 mg/ml, eye drops, solution Epinastine hydrochloride
Package leaflet: Information for the user Relestat, 0.5 mg/ml, eye drops, solution Epinastine hydrochloride Read all of this leaflet carefully before you start using this medicine because it contains important
More informationZovirax Ophthalmic (eye) Ointment Acyclovir
Zovirax Ophthalmic (eye) Ointment Acyclovir Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Zovirax ophthalmic ointment. It does not contain all the
More informationAPO-Latanoprost Contains the active ingredient latanoprost
APO-Latanoprost Contains the active ingredient latanoprost Consumer Medicine Information For a copy of a large print leaflet, Ph: 1800 195 055 What is in this leaflet Read this leaflet carefully before
More informationPATIENT INFORMATION LEAFLET
Page 1 of 6 PATIENT INFORMATION LEAFLET SCHEDULING STATUS Schedule 4 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM PRED FORTE Sterile Eye Suspension, prednisolone acetate 10 mg/ml sterile eye suspension
More informationAnterior uveitis (iritis) FAQ s
Patient information-medical retina Anterior uveitis (iritis) FAQ s This leaflet is intended for patients who attend Moorfields Eye Hospital, who are diagnosed with an eye condition called iritis- (a very
More informationJohn Rawstron Christchurch 2015
John Rawstron Christchurch 2015 John Rawstron Christchurch 2015 Nasal and temporal pterygiae (medial and lateral) pingueculum Body Neck Head Cap/hood Iles de Fuchs Stocker s line Pathogenesis UV light
More informationEye Diseases: Recognize These Common Eye Conditions
Eye Diseases: Recognize These Common Eye Conditions Many Americans Miss the Mark on Eye Diseases and Conditions. A recent survey of 1,000 adults shows that nearly half -- 47% -- worry more about losing
More information(5). (1, 5) Table 1:Appearance and location of dandruff, psoriasis and seborrhoeic dermatitis
A-Dandruff(pityriasis capitis) 1-Dandruff is a chronic relapsing condition of the scalp which respond to treatment, but return when the treatment is stopped (1). Increased cell turnover rate (twice the
More informationCool approach to managing hot lids
CET CONTINUING Sponsored by 1 CET POINT Cool approach to managing hot lids Amit Patel, MB BCh, FRCOphth Eyelid inflammation is a common condition encountered in both primary and secondary care, and encompasses
More informationAfatinib (Giotrif ) Your treatment Your doctor has prescribed you a treatment called afatinib (Giotrif ) which is a tablet and is taken orally.
Afatinib (Giotrif) Afatinib (Giotrif ) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer
More informationMedical and/or Vision Insurance plans do not cover the Specialty Dry Eye Testing or LipiFlow services.
ADVANCED BENEFICIARY NOTICE (ABN) Patient s Name: Date of Birth: The purpose of this form is to help you make an informed choice about your visit today. Before you make a decision about your options, you
More informationOphthalmic-1s: Antihistamine and Dual Acting Antihistamine/Mast Cell Stabilizers DHA Formulary Management Branch
May 2017 Antihistamine and Dual Acting Antihistamine/Mast Cell Stabilizers Executive Summary Page 1 of 5 Ophthalmic-1s: Antihistamine and Dual Acting Antihistamine/Mast Cell Stabilizers DHA Formulary Management
More informationTHE RED EYE When to treat, when to refer. Dr Beatrice Khater American University of Beirut November 2010
THE RED EYE When to treat, when to refer Dr Beatrice Khater American University of Beirut November 2010 OBJECTIVES Identify most common causes of Red Eye Know the adequate management of these conditions
More informationDo not use Allergo-COMOD eye drops - if you are hypersensitive against sodium cromoglicate (Ph. Eur.) or one of the other ingredients.
Allergo-COMOD eye drops 20 mg/ml eye drops Active substance: Sodium cromoglicate (Ph. Eur.) Read all of this leaflet carefully because it contains important information for you. This medicine is available
More informationOCULAR SURFACE DISEASE SYNDROMES WAYNE ISAEFF, MD LOMA LINDA UNIVERSITY DEPARTMENT OF OPHTHALMOLOGY
OCULAR SURFACE DISEASE SYNDROMES WAYNE ISAEFF, MD LOMA LINDA UNIVERSITY DEPARTMENT OF OPHTHALMOLOGY SURFACE DISEASE DRY EYE DYSFUNCTIONAL TEARS SYND ALLERGIC DISORDERS MEIBOMIAN GLAND PROBLEMS OCULAR IMMUNE
More informationDry eye syndrome is more likely to affect people who are over the age of 60, and the condition is more common among women than men.
DRY EYE Introduction Dry eye syndrome, also known as keratoconjunctivitis sicca, is a condition where your eyes do not make enough tears, or your tears evaporate too quickly. This can lead to your eyes
More informationPrecision Focus...From Every Angle. BEFORE & AFTER PRK SURGERY Patient Instruction Booklet.
Precision Focus...From Every Angle. BEFORE & AFTER PRK SURGERY Patient Instruction Booklet www.cascadiaeye.com Welcome To Cascadia Eye! This booklet is here to help you prepare for your PRK surgery and
More informationDry Eye Syndrome. A Guide
Dry Eye.qxp_IGA 16/05/2017 15:09 Page 1 Dry Eye Syndrome A Guide This free booklet is brought to you by the International Glaucoma Association (IGA). Contact the IGA for further information or advice:
More informationPATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops
Page 1 of 6 SCHEDULING STATUS Schedule 4 PATIENT INFORMATION LEAFLET PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops Read all of this leaflet carefully
More informationThis indication includes the temporary relief of burning, irritation, and/or discomfort due to dryness of the eye.
Page 1 of 5 SCHEDULING STATUS Schedule 0 PROPRIETARY NAME AND DOSAGE FORM REFRESH LIQUIGEL COMPOSITION REFRESH LIQUIGEL lubricant eye drops contain carboxymethylcellulose sodium 10 mg/ml. Preservative:
More informationPackage leaflet: Information for the patient. IKERVIS 1 mg/ml, eye drops, emulsion ciclosporin
Package leaflet: Information for the patient IKERVIS 1 mg/ml, eye drops, emulsion ciclosporin Read all of this leaflet carefully before you start using this medicine because it contains important information
More informationPackage Leaflet: Information for the user. NEVANAC 3 mg/ml eye drops, suspension nepafenac
Package Leaflet: Information for the user NEVANAC 3 mg/ml eye drops, suspension nepafenac Read all of this leaflet carefully before you start using this medicine because it contains important information
More informationCondition: Allergic Eye Disease (Type 1 Hypersensitivity reactions)
Condition: Allergic Eye Disease (Type 1 Hypersensitivity reactions) Description: Seasonal allergic conjunctivitis is caused by seasonal allergens, especially grass pollen, whereas perennial conjunctivitis
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol)
PACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol) Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet. You may
More informationPackage leaflet: Information for the user. <product name> 3 mg/ml eye drops, solution. Ofloxacin
Package leaflet: Information for the user 3 mg/ml eye drops, solution Ofloxacin Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. IOPIDINE 1% Apraclonidine Ophthalmic Solution, USP
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr IOPIDINE 1% Apraclonidine Ophthalmic Solution, USP Read this carefully before you start taking IOPIDINE 1% and each
More informationOcular Allergy. Phil Lieberman, MD
Ocular Allergy Phil Lieberman, MD Disclosure Consultant/Advisory Board: Genentech, Meda, Mylan, Teva Speaker: Genentech, Meda, Merck, Mylan, Teva Learning Objectives Upon completion of this session, participants
More informationDry Eye Syndrome Prescribing Guidelines
Dry Eye Syndrome Prescribing Guidelines Dry Eye Syndrome is a group of disorders of the ocular surface related to tear film abnormality, associated with ocular discomfort, visual symptoms and objective
More informationPATIENT INFORMATION LEAFLET
Page 1 PATIENT INFORMATION LEAFLET Please read this leaflet carefully before using COMBIGAN. Keep this leaflet. You may need to read it again. If you have any further questions, please ask your doctor
More informationMAINTAINING COMPLIANCE IN GLAUCOMA PATIENTS. by : Abdalla El-Sawy, M.D. Professor of Ophthalmology, Benha Faculty of Medicine.
MAINTAINING COMPLIANCE IN GLAUCOMA PATIENTS by : Abdalla El-Sawy, M.D. Professor of Ophthalmology, Benha Faculty of Medicine. The problem is especially critical for eye doctors who manage patients with
More informationCONSUMER INFORMATION. Sandoz Travoprost / Timolol PQ ophthalmic solution travoprost and timolol ophthalmic solution with POLYQUAD * as preservative
CONSUMER INFORMATION Pr Sandoz Travoprost / Timolol PQ ophthalmic solution travoprost and timolol ophthalmic solution with POLYQUAD * as preservative This leaflet is designed specifically for Consumers.
More informationTest Bank for Medical Surgical Nursing An Integrated Approach 3rd Edition by White
Test Bank for Medical Surgical Nursing An Integrated Approach 3rd Edition by White Link full download : http://testbankair.com/download/test-bank-for-medical-surgical-nursing-anintegrated-approach-3rd-edition-by-white/
More informationSUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Zaditen 0.25 mg/ml, eye drops, solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One ml contains 0.345 mg ketotifen fumarate corresponding
More informationPemetrexed APOTEX Powder for Injection Contains the active ingredient pemetrexed (as disodium)
Pemetrexed APOTEX Powder for Injection Contains the active ingredient pemetrexed (as disodium) Consumer Medicine Information For a copy of a large print leaflet, Ph: 1800 195 055 What is in this leaflet
More informationPackage leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution. Levofloxacin
Package leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution Levofloxacin Read all of this leaflet carefully before you start using this medicine because it contains important information
More informationThe Red Eye: Conjunctivitis, Iritis, or Worse? Sean P. Donahue, MD, PhD
The Red Eye: Conjunctivitis, Iritis, or Worse? Sean P. Donahue, MD, PhD Sam and Darthea Coleman Chair Vice Chair of Clinical Affairs, Department of Ophthalmology Professor of Pediatrics, Ophthalmology,
More informationMom, There s Something Wrong With My Eye
Mom, There s Something Wrong With My Eye Veeral Shah MD, PHD Texas Children's Hospital Most Common Issues Seen by the Pediatrician Emergent Ocular Issues Seen by the Pediatrician 1 What does this baby
More informationAllergic Rhinitis in Children
Allergic Rhinitis in Children Symptoms Rhinitis means inflammation of the mucous membranes in the nose. The common symptoms associated with rhinitis are an itchy nose, red eyes, watery discharge from the
More informationDRY EYE and MGD. Contact Central Maryland Eye Associates Today.
DRY EYE and MGD Contact Central Maryland Eye Associates Today. Now there is an Answer for Millions with Dry Eye There are nearly 30 million people in the United States and over 300 million worldwide who
More informationPrecision Focus...From Every Angle. BEFORE & AFTER LASIK SURGERY Patient Instruction Booklet.
Precision Focus...From Every Angle. BEFORE & AFTER LASIK SURGERY Patient Instruction Booklet www.cascadiaeye.com Welcome To Cascadia Eye! This booklet is here to help you prepare for your LASIK surgery
More informationWhat are the symptoms of a vulval skin condition?
Information for you Published in December 2013 Skin conditions of the vulva About this information This information is for you if you want to know about skin conditions affecting the vulva. If you are
More informationMedical and/or Vision Insurance plans do not cover the Specialty Dry Eye Testing or LipiFlow services.
ADVANCED BENEFICIARY NOTICE (ABN) Patient s Name: Date of Birth: The purpose of this form is to help you make an informed choice about your visit today. Before you make a decision about your options, you
More informationPhone Triage for Optometric Staff ???????? CHEMICAL BURN CHEMICAL BURN
Phone Triage for Optometric Staff There are very few ocular emergencies that you will have to deal with in practice, but it is imperative that you be able to Michelle Welch, O.D. NSU Oklahoma College of
More informationPRODUCT INFORMATION NAME OF THE MEDICINE DESCRIPTION PHARMACOLOGY. PATANOL * (Olopatadine) 0.1 % Eye Drops
PRODUCT INFORMATION PATANOL * (Olopatadine) 0.1 % Eye Drops NAME OF THE MEDICINE The active ingredient in PATANOL Eye Drops is olopatadine as its hydrochloride salt, or (Z)-11-[3-(dimethylamino)propylidene]-6-11-dihydrodibenz[b,e]oxepin-2-acetic
More informationSquint surgery in children
Manchester Royal Eye Hospital Paediatric Ophthalmology Services Information for Patients Squint surgery in children This leaflet provides information for parents/carers of children undergoing squint surgery.
More informationEYE CARE PROTOCOL FOR PATIENTS IN ITU
EYE CARE PROTOCOL FOR PATIENTS IN ITU Back to contents Developed by SUE LIGHTMAN PROFESSOR OF CLINICAL OPHTHALMOLOGY/CONSULTANT OPHTHALMOLOGIST MOORFIELDS EYE HOSPITAL Amended for UCLU ICU by Caroline
More informationThe Emergent Eye in the Acute Setting
The Emergent Eye in the Acute Setting Todd P. Margolis MD, PhD Professor of Ophthalmology & Director of the F.I. Proctor Foundation UCSF Physical Exam-- Visual Acuity Essential Corrected visual acuity
More informationPackage Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost
Package Leaflet: Information for the user LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost Read all of this leaflet carefully before you start using this medicine because it
More informationConjunctivitis in dogs
Conjunctivitis in dogs Overview Conjunctivitis means inflammation (swelling) of the conjunctiva and can be caused by many different conditions. The conjunctiva is a very thin layer of tissue that covers
More informationFocusing on A&E. By Sandy Cooper, (Ophthalmic Nurse Practitioner), Tel
Focusing on A&E By Sandy Cooper, (Ophthalmic Nurse Practitioner), Tel 01752 439331 Email sandra.cooper5@nhs.net sandracooper041@btinternet.com THINGS TO WORRY ABOUT WITH ANY EYE PROBLEM CHANGES IN VISION
More informationChemical Name: 4H-Pyrano[3,2-g]quinoline-2,8-dicarboxylic acid, 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-, disodium salt.
ALCRIL (nedocromil sodium ophthalmic solution) 2% sterile DESCRIPTIN ALCRIL (nedocromil sodium ophthalmic solution) 2% is a clear, yellow, sterile solution for topical ophthalmic use. Nedocromil sodium
More informationPackage leaflet: Information for the user. PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate
Package leaflet: Information for the user PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate Read all of this leaflet carefully before you start using this medicine
More information